Longeveron Inc. SEC filings LGVN

Longeveron Inc. has 530 filings in SEC EDGAR's recent list, going back to Nov 6, 2017. Its latest annual report, Form ARS, was filed on May 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.

Longeveron Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 26, 2026 Oct 26, 2026
8-K Current report
Officer or director change
Oct 14, 2026 Oct 7, 2026
8-K Current report
Other events
Sep 23, 2026 Sep 16, 2026
8-K Current report
Other events
Sep 14, 2026 Sep 11, 2026
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Aug 24, 2026 Aug 20, 2026
8-K Current report
Officer or director change
Aug 19, 2026 Aug 17, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 29, 2026 Jul 24, 2026
8-K Current report
Officer or director change
Jul 14, 2026 Jul 8, 2026
S-8 Employee stock plan registration Jul 10, 2026 —
8-K Current report
Officer or director change
Jul 8, 2026 Jul 8, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jul 6, 2026 Jun 30, 2026
8-K Current report
Officer or director change
Jun 5, 2026 Jun 1, 2026
ARS Annual report to shareholders May 20, 2026 Dec 31, 2025
DEFA14A Additional proxy material May 20, 2026 —
DEF 14A Proxy statement May 20, 2026 Jul 1, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Other events
May 8, 2026 May 8, 2026
PRE 14A Preliminary proxy statement May 5, 2026 May 5, 2026
EFFECT Filing Apr 17, 2026 —
424B3 Prospectus Apr 17, 2026 —
CORRESP Letter to the SEC Apr 15, 2026 —
UPLOAD Letter from the SEC Apr 14, 2026 —
8-K Current report
Officer or director change
Apr 10, 2026 Mar 25, 2026
S-1 Registration statement Apr 10, 2026 —
8-K Current report
Listing notice
Mar 25, 2026 Mar 24, 2026
D Filing Mar 25, 2026 —
8-K Current report
Other events
Mar 24, 2026 Mar 23, 2026
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Mar 12, 2026 Mar 10, 2026
8-K Current report
Listing notice, Officer or director change
Mar 9, 2026 Mar 3, 2026
PRE 14A Preliminary proxy statement Mar 3, 2026 Mar 3, 2026
8-K Current report
Officer or director change
Feb 13, 2026 Feb 9, 2026
8-K Current report
Officer or director change
Nov 12, 2025 Nov 7, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Officer or director change
Oct 1, 2025 Sep 25, 2025
8-K Current report
Listing notice
Sep 26, 2025 Sep 22, 2025
8-K Current report
Material agreement
Sep 19, 2025 Sep 19, 2025
424B5 Prospectus supplement Sep 19, 2025 —
8-K Current report
Officer or director change
Sep 3, 2025 Aug 27, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Material agreement, Other events
Aug 11, 2025 Aug 8, 2025
424B4 Prospectus Aug 11, 2025 —
EFFECT Filing Aug 8, 2025 —
CORRESP Letter to the SEC Aug 8, 2025 —
CORRESP Letter to the SEC Aug 8, 2025 —
S-1/A Amended registration statement Aug 8, 2025 —
S-1 Registration statement Aug 4, 2025 —
UPLOAD Letter from the SEC Jul 25, 2025 —
DRS Filing Jul 21, 2025 —
8-K Current report
Other events
Jul 9, 2025 Jul 8, 2025
S-8 Employee stock plan registration Jun 20, 2025 —
8-K Current report
Shareholder vote results
Jun 16, 2025 Jun 13, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Officer or director change
May 1, 2025 Apr 24, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 13, 2025
EFFECT Filing Apr 4, 2025 —
CORRESP Letter to the SEC Apr 2, 2025 —
UPLOAD Letter from the SEC Mar 31, 2025 —
S-3 Shelf registration Mar 28, 2025 —
8-K Current report
Auditor change
Mar 14, 2025 Mar 13, 2025
8-K Current report
Results of operations
Feb 28, 2025 Dec 31, 2024
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Jan 30, 2025 Jan 27, 2025
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
EFFECT Filing Aug 12, 2024 —
424B3 Prospectus Aug 12, 2024 —
CORRESP Letter to the SEC Aug 9, 2024 —
UPLOAD Letter from the SEC Aug 8, 2024 —
S-1 Registration statement Aug 6, 2024 —
D Filing Jul 23, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 19, 2024 Jul 18, 2024
424B5 Prospectus supplement Jul 19, 2024 —
8-K Current report
Other events
Jul 17, 2024 Jul 17, 2024
S-8 Employee stock plan registration Jul 10, 2024 —
424B3 Prospectus Jul 10, 2024 —
8-K Current report
Other events
Jul 10, 2024 Jul 10, 2024
EFFECT Filing Jul 9, 2024 —
CORRESP Letter to the SEC Jul 5, 2024 —
8-K Current report
Shareholder vote results
Jul 3, 2024 Jul 2, 2024
UPLOAD Letter from the SEC Jul 3, 2024 —
S-1 Registration statement Jun 28, 2024 —
D Filing Jun 25, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jun 18, 2024 Jun 17, 2024
424B3 Prospectus May 22, 2024 —
EFFECT Filing May 21, 2024 —
S-1/A Amended registration statement May 21, 2024 —
DEFA14A Additional proxy material May 20, 2024 —
DEF 14A Proxy statement May 20, 2024 Jul 2, 2024
ARS Annual report to shareholders May 20, 2024 Dec 31, 2023
CORRESP Letter to the SEC May 17, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Listing notice, Officer or director change
May 10, 2024 May 6, 2024
UPLOAD Letter from the SEC May 6, 2024 —
S-1 Registration statement Apr 30, 2024 —
D Filing Apr 25, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Apr 18, 2024 Apr 16, 2024
EFFECT Filing Apr 17, 2024 —
424B4 Prospectus Apr 17, 2024 —
CORRESP Letter to the SEC Apr 16, 2024 —
S-1/A Amended registration statement Apr 16, 2024 —
8-K Current report
Material agreement, Other events
Apr 11, 2024 Apr 8, 2024
424B3 Prospectus Apr 10, 2024 —
424B4 Prospectus Apr 10, 2024 —
EFFECT Filing Apr 8, 2024 —
CORRESP Letter to the SEC Apr 8, 2024 —
CORRESP Letter to the SEC Apr 8, 2024 —
FWP Free writing prospectus Apr 8, 2024 —
S-1/A Amended registration statement Apr 5, 2024 —
S-1/A Amended registration statement Apr 3, 2024 —
UPLOAD Letter from the SEC Mar 27, 2024 —
S-1 Registration statement Mar 19, 2024 —
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Mar 19, 2024 Mar 19, 2024
10-K/A Amended annual report Mar 11, 2024 Dec 31, 2023
8-K Current report
Listing notice
Mar 7, 2024 Mar 4, 2024
CORRESP Letter to the SEC Mar 1, 2024 —
10-K Annual report Feb 27, 2024 Dec 31, 2023
8-K Current report
Shareholder vote results
Feb 22, 2024 Feb 21, 2024
UPLOAD Letter from the SEC Feb 9, 2024 —
DEF 14A Proxy statement Feb 5, 2024 Feb 21, 2024
S-1 Registration statement Jan 29, 2024 —
PRE 14A Preliminary proxy statement Jan 25, 2024 Jan 25, 2024
D Filing Jan 8, 2024 —
8-K Current report
Shareholder vote results
Dec 28, 2023 Dec 26, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 22, 2023 Dec 20, 2023
424B5 Prospectus supplement Dec 22, 2023 —
424B3 Prospectus Dec 6, 2023 —
EFFECT Filing Nov 21, 2023 —
CORRESP Letter to the SEC Nov 17, 2023 —
UPLOAD Letter from the SEC Nov 16, 2023 —
S-1 Registration statement Nov 15, 2023 —
DEFA14A Additional proxy material Nov 14, 2023 —
DEF 14A Proxy statement Nov 14, 2023 Dec 26, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
PRE 14A Preliminary proxy statement Nov 2, 2023 Nov 2, 2023
D Filing Oct 24, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 13, 2023 Oct 11, 2023
424B5 Prospectus supplement Oct 13, 2023 —
8-K Current report
Other events
Oct 5, 2023 Oct 5, 2023
8-K Current report
Other events
Sep 25, 2023 Sep 21, 2023
25-NSE Delisting notice Sep 21, 2023 —
8-K Current report
Material agreement
Aug 18, 2023 Aug 14, 2023
8-K Current report
Other events
Aug 16, 2023 Aug 16, 2023
CERT Filing Aug 16, 2023 —
EFFECT Filing Aug 14, 2023 —
8-A12B For registration of certain classes Aug 14, 2023 —
424B3 Prospectus Aug 14, 2023 —
8-K Current report
Other events
Aug 14, 2023 Aug 14, 2023
CORRESP Letter to the SEC Aug 11, 2023 —
S-1/A Amended registration statement Aug 11, 2023 —
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
S-1/A Amended registration statement Jul 28, 2023 —
CORRESP Letter to the SEC Jul 28, 2023 —
8-K Current report
Officer or director change
Jul 20, 2023 Jul 20, 2023
UPLOAD Letter from the SEC Jul 11, 2023 —
8-K Current report
Officer or director change
Jul 5, 2023 Jun 30, 2023
S-1 Registration statement Jun 27, 2023 —
S-8 Employee stock plan registration Jun 26, 2023 —
8-K Current report
Regulation FD disclosure
Jun 23, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
Jun 12, 2023 Jun 9, 2023
8-K Current report
Officer or director change
Jun 5, 2023 Jun 1, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 12, 2023 May 12, 2023
DEFA14A Additional proxy material Apr 28, 2023 —
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 28, 2023 Jun 9, 2023
8-K Current report
Officer or director change
Apr 10, 2023 Apr 4, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 10, 2023 Mar 10, 2023
8-K Current report
Officer or director change
Feb 28, 2023 Feb 22, 2023
8-K Current report
Officer or director change
Jan 27, 2023 Jan 23, 2023
8-K Current report
Regulation FD disclosure
Jan 6, 2023 Jan 6, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Officer or director change
Nov 3, 2022 Oct 28, 2022
8-K Current report
Regulation FD disclosure
Sep 1, 2022 Aug 31, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 12, 2022 Aug 12, 2022
8-K Current report
Shareholder vote results
Jun 27, 2022 Jun 24, 2022
8-K Current report
Officer or director change
Jun 7, 2022 Jun 3, 2022
DEFA14A Additional proxy material May 13, 2022 —
DEF 14A Proxy statement May 13, 2022 Jun 24, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
8-K Current report
Officer or director change
May 9, 2022 May 3, 2022
EFFECT Filing Apr 14, 2022 —
CORRESP Letter to the SEC Apr 12, 2022 —
UPLOAD Letter from the SEC Apr 12, 2022 —
S-3 Shelf registration Apr 5, 2022 —
8-K Current report
Officer or director change
Apr 5, 2022 Apr 1, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LGVN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
, Emerging growth company
SEC CIK
1721484
Former names
LONGEVERON LLC (until Feb 10, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.